Steven K. Budd, Chief Executive Officer
Steven is a twenty-five year veteran of the pharmaceutical industry with a wide
range of experience in sales, marketing and medical communications. He has been
involved in the outsourced sales industry since its formative years and is a respected
expert on US Healthcare outsourcing trends. Prior to joining IMC he spent 11 years
at PDI, serving as President since 2000. At PDI he helped vault the company to a
leadership position in providing sales and marketing services to the bio-pharmaceutical
industry, at its peak achieving revenues in excess of $400 million with four thousand
employees and a market valuation of over $1 billion. Before joining PDI, Steve held
senior level positions at PDN (now the Professional Sales Division of Publicis)
and Innovex, Inc. He began his career as a pharmaceutical sales rep in 1980 and
held mid-to senior-level sales management positions before moving over to the service
side of the industry in 1990. Mr. Budd received a B.A. in History and Education
from
Susquehanna
University
in 1978.
Kathleen Bresette
, Executive Vice President, IMC & President, The Peer Group
Kathleen has been with The Peer Group since 1996. She began as a moderator, serving
in that role for four years before joining the client service team. In 2004, she
became Executive Vice President of The Peer Group, growing the company’s revenues
50 percent, and in 2005 was promoted to President. She has an undergraduate degree
and a master's degree in public health, both from Boston University.
Bert Marchio
, Executive Vice President/Chief Financial Officer
Bert brings to IMC over 20 years of experience in senior financial leadership positions
in both the public and private sectors, with the last 15 years spent in the pharmaceutical
industry. Prior to IMC, he served as Vice President, Treasurer of MedPointe
where he helped lead the financial turnaround and eventual sale of the company.
During his tenure, the value of MedPointe shares doubled and the company saw a dramatic
improvement in cash flow. Bert also helped finance the domestic and international
growth of Alpharma from under $300MM in sales (1992) to approximately $1.3B (2005)
while building treasury, tax, risk management and benefit finance systems as their
Vice President, Treasurer. Bert holds a BA in Economics from
Muhlenberg
College
, an MBA in Professional Accounting from Rutgers Graduate School of Business and
a Post-MBA Certificate in Taxation from
Bernard Baruch
College
.
Seth Freedman
, Senior Vice President, Corporate Development
Seth brings over 15 years of healthcare experience working to grow healthcare content/media
businesses, pharmaceutical companies, and healthcare providers. Seth recently organized
the sale of IMC’s HealthTalk business to Revolution Health Group LLC, which was
created by AOL Co-Founder Steve Case. Prior to joining IMC, he helped drive business
development at the Thomson Corporation, including strategic planning, merger and
acquisition activity, and organic growth opportunities. Previously, he served as
a management consultant at PricewaterhouseCoopers' Healthcare practice working on
strategic and operational projects for physician groups, healthcare systems, payors
and pharmaceutical companies.
Jaime Nguyen, Medical Director/Compliance Officer
Jaime was appointed to this position following two years of distinguished service
as a moderator on numerous IMC programs. Jaime holds an MD from MSIH and
Columbia
University
Medical
Center
, an MPH from the
University
of
Pittsburgh
, and an MS in Medicinal Chemistry and Pharmacology from the
University of Toledo
. Additionally, Jaime is a certified Pharmaceutical, Biotech and Medical Device
Compliance Officer. Prior to joining IMC in 2006, Jaime had over 10 years
of experience in the areas of pharmacology and drug design, medicine and public
health, and healthcare analysis. She also held numerous international clinical
leadership roles across multiple therapeutic areas and served on two federal advisory
committees while working for the Department of Health and Human Services.
Scott Stoogenke
, Vice President, Marketing
Scott
has over 15 years of life sciences marketing experience, including pharmaceutical
brand management and service provider marketing leadership. Prior to IMC,
he worked for Covance, Inc. as Director of Corporate Marketing, managing the corporate
branding initiative, conferences, e-marketing, and marketing communications.
Previously, he worked for PDI, Inc. as Executive Director of Marketing, providing
strategic corporate marketing and business development support. His experience
also includes a breadth of marketing roles at GlaxoSmithKline and Novo Nordisk,
including product management, market research, forecasting, competitive intelligence,
managed care marketing, and pipeline development in multiple therapeutic areas.
In addition to his work experience,
Scott
holds an MBA in marketing/international business from the University of Maryland
Smith School of Business, an MA in education/human development from the
George
Washington
University
, and a BS in biochemistry/molecular biology from the
University of Maryland
.